Nicola Price Selected Research

TV-45070

1/2017	Safety and Efficacy of a Topical Sodium Channel Inhibitor (TV-45070) in Patients With Postherpetic Neuralgia (PHN): A Randomized, Controlled, Proof-of-Concept, Crossover Study, With a Subgroup Analysis of the Nav1.7 R1150W Genotype.
1/2012	Treatment of Na(v)1.7-mediated pain in inherited erythromelalgia using a novel sodium channel blocker.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Nicola Price Research Topics

Disease

2	Pain (Aches) 01/2017 - 01/2012
2	Infections 02/2007 - 08/2002
1	Kaposi Sarcoma (Kaposi's Sarcoma) 01/2019
1	Postherpetic Neuralgia 01/2017
1	Congenital Pain Insensitivity 01/2012
1	Erythromelalgia (Erythermalgia) 01/2012
1	Inborn Genetic Diseases (Disease, Hereditary) 01/2012
1	Human Influenza (Influenza) 01/2011
1	Virus Diseases (Viral Diseases) 01/2011
1	Rupture 02/2007

Drug/Important Bio-Agent (IBA)

2	Sodium Channel BlockersIBA 01/2017 - 01/2012
2	TV-45070IBA 01/2017 - 01/2012
1	DNA (Deoxyribonucleic Acid)IBA 01/2019
1	Ointments (Pastes)IBA 01/2017
1	Proteins (Proteins, Gene)FDA Link 01/2012
1	Analgesics (Analgesic Drugs)IBA 01/2012
1	Hemagglutinins (Hemagglutinin)IBA 01/2011
1	Neuraminidase (Sialidase)IBA 01/2011
1	Zanamivir (Relenza)FDA Link 01/2011
1	Oseltamivir (Tamiflu)FDA Link 01/2011
1	Antiviral Agents (Antivirals)IBA 02/2007
1	Glycoproteins (Glycoprotein)IBA 08/2002

Therapy/Procedure

1	Therapeutics 01/2011
1	Cesarean Section (Caesarean Section) 02/2007